DNA Synthesis Industry Overview

The global DNA synthesis market size was estimated at USD 3.13 billion in 2023 and is projected to grow at a CAGR of 15.30% from 2024 to 2030.

Market growth can be attributed to the increasing demand for DNA synthesis due to its applications in molecular biology, genetic engineering, and clinical diagnostics & therapeutics. In addition, the growing demand for research in drug discovery and personalized medicine is likely to impact market growth positively over the forecast period.

Gather more insights about the market drivers, restrains and growth of the DNA Synthesis Market

DNA synthesis has evolved from a primarily research-focused tool to becoming a cornerstone in clinical diagnostics, offering valuable insights into the genetic underpinning of diseases and contributing to more accurate diagnoses & personalized treatment approaches. DNA synthesis has enabled an understanding of genetic variations that may contribute to an individual's susceptibility to diseases or influence the progression of existing conditions. This is particularly evident in the field of cancer genomics, where DNA synthesis is used to characterize the genomic landscape of tumors, identify driver mutations, and guide targeted therapies.

In addition, the field of synthetic biology focused on the design & construction of biological components and systems for novel applications, relies heavily on custom gene synthesis. The rise of gene therapy and genome editing technologies, such as CRISPR-Cas9, requires custom gene synthesis for designing therapeutic genes, regulatory elements, and gene editing tools. Upon realizing the high potential of genomics in medicine and healthcare, researchers are being encouraged to conduct studies based on artificial gene synthesis. Programs such as the Precision Medicine Initiative, and advancements in companion diagnostic studies have increased the adoption of expression analysis. A high number of expression studies that utilize probes and primers is anticipated to boost the demand for DNA synthesis.

Furthermore, the regulatory environment for genetic research varies from country to country. Many developed and emerging countries recently introduced changes in the regulatory policies related to gene editing and genetic engineering. Identifying the potential applications of genetics in medicine and human health, restrictions on genetic studies have been lifted to allow research for medicine and health. This provides researchers an opportunity to practically implement existing knowledge as well as explore novel approaches.

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global precision medicine market size was estimated at USD 87.50 billion in 2023 and is projected to grow at a CAGR of 16.3% from 2024 to 2030.
• The global gene therapy market size was estimated at USD 5.54 billion in 2023 and is projected to grow at a CAGR of 18.88% from 2024 to 2030.

DNA Synthesis Market Segmentation

Grand View Research has segmented the global DNA synthesis market on the basis of service type, application, end-use, and region:

DNA Synthesis Service Type Outlook (Revenue, USD Million, 2018 - 2030)

• Oligonucleotide Synthesis
• Standard Oligonucleotide Synthesis
• Custom Oligonucleotide Synthesis
• Gene Synthesis
• Custom Gene Synthesis
• Gene Library Synthesis

DNA Synthesis Length Outlook (Revenue, USD Million, 2018 - 2030)

• Oligonucleotide Synthesis
• Gene Synthesis

DNA Synthesis Application Outlook (Revenue, USD Million, 2018 - 2030)

• Research and Development
• Diagnostics
• Therapeutics

DNA Synthesis End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical and Diagnostics Companies
• Academic and Research Institutes
• Contract Research Organizations

DNA Synthesis Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait 

Key Companies profiled:

• Thermo Fisher Scientific, Inc
• Twist Bioscience
• BIONEER CORPORATION
• Eton Bioscience, Inc.
• LGC Biosearch Technologies
• IBA Lifesciences GmbH
• Eurofins Scientific
• Integrated DNA Technologies, Inc.
• Quintara Biosciences
• GenScript 

Recent Developments

• In May 2024, Molecular Assemblies, Inc. initiated a Partnering Program aimed at granting licenses for the company’s Full Enzymatic Synthesis technology. Through this collaborative effort, limited participants will be provided with the company’s automated synthesis platform, any advancements or refinements to its FES platform, and the requisite licenses to conduct FES for research purposes within their facilities.  
• In November 2023, QIAGEN and Element Biosciences, Inc. partnered strategically to provide broad NGS workflows for the innovative sequencing platform Element AVITI System.
• In April 2023, Eurofins BioPharma Product Testing (Eurofins Scientific) completed a substantial expansion of its Stability Services offering at the Lancaster, PA, facility. This is anticipated to boost the demand for DNA synthesis production.
• In February 2023, Tecan and Element Biosciences collaborated to provide a benchtop NGS workflow with MagicPrep NGS. The product is AVITI System, an innovative DNA sequencing platform by Element Biosciences, Inc.

Order a free sample PDF of the DNA Synthesis Market Intelligence Study, published by Grand View Research.